Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Dhingra
Anurag Dhingra, San Jose, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090174764 | System and Method for Displaying a Multipoint Videoconference - A method for displaying a multipoint videoconference includes receiving a plurality of video signals generated at a plurality of remote conference sites. The method includes assigning a plurality of video signals generated at a first remote conference site to a first monitor of a plurality of monitors at a local site and assigning a plurality of video signals generated at a second remote conference site to a second monitor of the plurality of monitors at the local site. In addition, the method includes selecting, for each of the first and second monitor, a video signal of the plurality of video signals assigned to the monitor, and displaying each selected video signal on its respective monitor. | 07-09-2009 |
Anurag Dhingra, Fremont, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080259791 | METHOD AND APPARATUS FOR NORMALIZING SERVICE LEVEL AGREEMENTS IN A NETWORK - This disclosure provides a method and apparatus for normalizing service level agreements across entire networks. By utilizing a new parameter called the virtual call count, a wholesale network provider can monitor a variety of related network status indications and provide to their customers increased insight into the nature of the service level rejections that they experience. Existing service level agreement processors can be equipped with the additional functionality of calculating the virtual call count to form an apparatus for normalizing service level agreements. | 10-23-2008 |
Atul K. Dhingra, Houston, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20080300464 | Laryngoscope with Timer - A laryngoscope comprising a handle, a blade coupled to the handle, wherein the blade is movable between an operational position and a non-operational position. The laryngoscope also comprises a timer, wherein the timer is in communication with the handle or the blade of the laryngoscope, the timer being operative to measure a time period in which the blade is in the operational position. | 12-04-2008 |
Dalia M. Dhingra, Arlington Heights, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20110275066 | METHOD OF DNA ANALYSIS USING MICRO/NANOCHANNEL - Methods are provided for tagging, characterizing and sorting double-stranded biomolecules while maintaining the integrity of the biomolecules. | 11-10-2011 |
Gaurav Dhingra, Spring, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20120073823 | SYSTEM FOR SUBSEA EXTRACTION OF GASEOUS MATERIALS FROM, AND PREVENTION, OF HYDRATES - A system for subsea extraction of gaseous materials from and preventing the formation of hydrates. | 03-29-2012 |
Gurmeet Singh Dhingra, Bangalore IN
| Patent application number | Description | Published |
|---|---|---|
| 20100082497 | Providing Foundation Application as Enterprise Services - Methods and apparatus, including systems and computer program products, for a services architecture design that provides enterprise services having foundation layer functionality at the level of an enterprise application. The design includes a set of service operations, process components, and optionally deployment units. Suitable business objects are also described. | 04-01-2010 |
| 20110307363 | Managing Consistent Interfaces for Currency Conversion and Date and Time Business Objects Across Heterogeneous Systems - A business object model, which reflects data that is used during a given business transaction, is utilized to generate interfaces. This business object model facilitates commercial transactions by providing consistent interfaces that are suitable for use across industries, across businesses, and across different departments within a business during a business transaction. In some operations, software creates, updates, or otherwise processes information related to Currency Conversion and Date and Time business objects. | 12-15-2011 |
| 20120047079 | PROVIDING FOUNDATION APPLICATION AS ENTERPRISE SERVICES - Methods and apparatus, including systems and computer program products, for a services architecture design that provides enterprise services having foundation layer functionality at the level of an enterprise application. The design includes a set of service operations, process components, and optionally deployment units. Suitable business objects are also described. | 02-23-2012 |
Harish Chandra Dhingra, Friendswood, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20120017564 | SUPERCONDUCTIVE HEAT TRANSFER SYSTEM - A system, including a superconductive heat transfer assembly, including, a first superconductive heat transfer pipe, a second superconductive heat transfer pipe, and a superconductive heat transfer contact switch configured to open and close a gap between the first superconductive heat transfer pipe and the second superconductive heat transfer pipe. | 01-26-2012 |
| 20120031600 | TURBINE INTERCOOLER - An intercooler includes a shell with an inlet and an outlet. The shell defines a first chamber. The intercooler further includes a plurality of elongate conducting members. Each of the conducting members includes a first end section and a second end section and is disposed such that each of the first end sections is inside the first chamber of the shell and such that each of the second end sections is disposed exteriorly of the shell. Each of the second end sections is disposed in a flow path of at least one cooling medium so as to undergo evaporative cooling. | 02-09-2012 |
Kapil Dhingra, Sparta, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20120045433 | COMBINATION THERAPY - The present invention relates to a combination therapy of propane-1-sulfonic acid {3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide, or a pharmaceutically acceptable salt thereof, and an topoisomerase inhibitor for treating a patient suffering from a proliferative disorder, in particular a solid tumor, for example, colorectal cancer, melanoma, and thyroid cancer. In particular, the present invention relates to such a therapy wherein the topoisomerase inhibitor is irinotecan, or a pharmaceutically acceptable salt thereof, and the disorder is colorectal cancer involving a tumor comprising b-Raf having the V600E mutation. | 02-23-2012 |
| 20120045434 | COMBINATION THERAPY - The present invention relates to a combination therapy of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide, or a pharmaceutically acceptable salt thereof, and an EGFR inhibitor for treating a patient suffering from a proliferative disorder, in particular a solid tumor, for example, colorectal cancer, melanoma, and thyroid cancer. | 02-23-2012 |
Kavita Dudeja Dhingra, Delhi IN
| Patent application number | Description | Published |
|---|---|---|
| 20110166900 | Testing and Evaluating the Recoverability of a Process - Aspects of this disclosure relate to a computer for determining the recoverability of a process which may include a processor and memory storing computer executable instructions that, when executed, cause the computer to determine the recoverability of a process, by receiving data relating to a contingency plan for recovering the process, receiving data relating to an organization's execution of the contingency plan during a test of the recoverability of the process, and determining the recoverability of the process based on the data by calculating a cumulative overall score for the recoverability of the process, comparing the cumulative overall score with a rating chart stored in the computer, which includes numerical ranges defining a level of assurance of the recoverability of the process, and determining the recoverability of a process based on the comparison of the cumulative overall score with the rating chart. | 07-07-2011 |
Narender K. Dhingra, Haryana IN
| Patent application number | Description | Published |
|---|---|---|
| 20100329989 | In Vivo Labeling of Mammalian Cone Photoreceptors by Intravitreal Injection of Fluorescently Tagged Peanut Agglutinin - A method for specifically labeling of mammalian cone photoreceptors in vivo comprising injecting a mammal with peanut agglutinin conjugated with a fluorescent probe. The peanut agglutinin labels the cone photoreceptor. | 12-30-2010 |
Neelima Dhingra, Chandigarh IN
| Patent application number | Description | Published |
|---|---|---|
| 20100234472 | NITRIC OXIDE RELEASING DERIVATIVES OF PARACETAMOL - The present invention particularly relates to novel nitrate esters of paracetamol. The nitrate esters of paracetamol are prepared by reacting the paracetamol with dihaloalkyl compound and followed by reaction with silver nitrate to obtain the corresponding nitrate ester derivatives. The nitrate esters of paracetamol are useful as analgesic, anti-inflammatory agents. | 09-16-2010 |
| 20100292201 | NOVEL STEROIDAL ESTERS OF 17-OXIMINO-5-ANDROSTEN-3BETA-OL - The present invention relates to steroidal esters of 17-oximino-5-androsten-3-ol, of compound of general formula (A) wherein R is selected from a group consisting of arylalkyl, aryl, substituted aryl. The ester derivatives are synthesized starting from Dehydroandrosterone acetate. The compounds were tested for their antiproliferative activity and 5α-reductase inhibitory activity in comparison to Finasteride. Decreased androgen level have been found in serum of animal treated with newly synthesized compounds. These compounds have also shown better cytotoxicity in comparison to reference drug Finasteride. Thus such compounds can be useful in treatment of androgen dependent disorder of prostate alone or by synergistic effect they can decrease the size of prostate due to their antiproliferative activity. | 11-18-2010 |
Om Dhingra, Morrisville, NC US
| Patent application number | Description | Published |
|---|---|---|
| 20110160168 | MODULATION OF SOLUBILITY, STABILITY, ABSORPTION, METABOLISM, AND PHARMACOKINETIC PROFILE OF LIPOPHILIC DRUGS BY STEROLS - A formulation for drug delivery, providing enhanced modulation of solubility, stability, absorption, metabolism, and/or pharmacokinetic profile of a lipophilic therapeutic agent by formulation with sterols and/or sterol esters, resulting in higher bioavailability of a therapeutic agent administered to a subject in need of such therapeutic agent. The formulation contains a therapeutic agent and a sterol or sterol ester, and can, optionally, further contain a solubilizer and/or an enhancing agent. Also described are pharmaceutical compositions containing the formulations and methods of making and methods of using the formulations and pharmaceutical compositions. Formulations of the disclosure can be constituted to minimize the synthesis of dihydrotestosterone when the therapeutic agent includes testosterone or testosterone esters. | 06-30-2011 |
| 20110263552 | MODULATION OF SIDE EFFECT PROFILE OF 5-ALPHA REDUCTASE INHIBITOR THERAPY - Methods for modulating one or more side effects of 5-α-reductase inhibitor therapy are provided, where the method includes administering a 5-α-reductase inhibitor and testosterone undecanoate. Also provided are methods of maintaining or restoring a DHT serum level in an individual undergoing 5-α-reductase inhibitor therapy, where the method includes administering testosterone undecanoate in addition to 5-α-reductase inhibitor. Further provided are methods of treating or preventing a DHT-related condition, such as benign prostate hyperplasia (BPH) or prostate cancer by administering a 5-α-reductase inhibitor and testosterone undecanoate. | 10-27-2011 |
Prashant Dhingra, Redmond, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20110295677 | EVENT-BASED AD TARGETING - Embodiments of the present invention enable an advertiser to target ads to users based on occurrences of events that may influence the purchasing behavior of the users. The advertiser may specify an event to be used in targeting an ad. The event's region of influence is determined, and ads are targeted to users that are located within the region of influence. | 12-01-2011 |
Prashant Kumar Dhingra, Redmond, WA US
| Patent application number | Description | Published |
|---|---|---|
| 20110126113 | DISPLAYING CONTENT ON MULTIPLE WEB PAGES - Aspects of the subject matter described herein relate to displaying content on multiple pages. In aspects, a request for content is received from a browsing component. The content is divided into pages suitable for displaying on a display associated with the browsing component. Navigation elements may be embedded in the pages to allow a user using the browsing component to navigate between pages corresponding to the content. The actions of dividing the content into multiple pages may occur on a content server, an entity intermediate to the content server and a client hosting the browsing component, or a component of the client. | 05-26-2011 |
Sandeep Dhingra, Sunnyvale, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090138239 | DETERMINING OVERALL NETWORK HEALTH AND STABILITY - A network health analyzer that analyzes health of a computer network may be implemented in accordance with an embodiment of the present invention. A network profile comprising an issue profile and one or more benchmarks appropriate for the network is determined. A set of numeric measures that is common to all issues in the issue profile is established. The network health analyzer collects data points pertaining to the operation of the network. Based on the data points, numeric values corresponding to the numeric measures may be calculated. In turn, health indexes for all issues in the issue profile may be determined. Based on these health indexes for the issues, an overall health rating may be determined. | 05-28-2009 |
| 20110166829 | Determining Overall Network Health And Stability - A network health analyzer that analyzes health of a computer network may be implemented in accordance with an embodiment of the present invention. A network profile comprising an issue profile and one or more benchmarks appropriate for the network is determined. A set of numeric measures that is common to all issues in the issue profile is established. The network health analyzer collects data points pertaining to the operation of the network. Based on the data points, numeric values corresponding to the numeric measures may be calculated. In turn, health indexes for all issues in the issue profile may be determined. Based on these health indexes for the issues, an overall health rating may be determined. | 07-07-2011 |
Sandeep S. Dhingra, Midland, MI US
| Patent application number | Description | Published |
|---|---|---|
| 20100076208 | HYDRO-OXIDATION PROCESS USING A CATALYST PREPARED FROM A GOLD CLUSTER COMPLEX - A process and catalyst for the hydro-oxidation of an olefin having three or more carbon atoms, such as propylene, to form an olefin oxide, such as propylene oxide. The process involves contacting the olefin with oxygen in the presence of hydrogen and a hydro-oxidation catalyst under reaction conditions; the catalyst comprising gold nanoparticles deposited on a nanoporous titanium-containing support, prepared by depositing a gold-ligand cluster complex onto the support to form a catalyst precursor, and then heating and/or chemically treating the catalyst precursor to form the hydro-oxidation catalyst composition. The hydro-oxidation catalyst exhibits stabilized catalyst activity, enhanced lifetime, and improved hydrogen efficiency. | 03-25-2010 |